MeSH term
Frequency | Condition_Probility | Alleles | 5 | 0.0 |
Female | 22 | 0.0 |
Heterozygote | 2 | 0.0 |
Humans | 46 | 0.0 |
Male | 26 | 0.0 |
Mast Cells/*enzymology | 5 | 19.0 |
Middle Aged | 12 | 0.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Serine Endopeptidases/*genetics | 5 | 9.0 |
*Variation (Genetics) | 2 | 0.0 |
Adenocarcinoma/*genetics | 2 | 1.0 |
Adult | 15 | 0.0 |
Aged | 9 | 0.0 |
Esophageal Neoplasms/*genetics | 3 | 4.0 |
Loss of Heterozygosity | 5 | 0.0 |
Microsatellite Repeats | 2 | 0.0 |
Mutation | 5 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
English Abstract | 6 | 0.0 |
*Genes, Tumor Suppressor | 7 | 0.0 |
*Loss of Heterozygosity | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
Base Sequence | 11 | 0.0 |
Carbon-Carbon Ligases/*deficiency/*genetics | 3 | 100.0 |
DNA Mutational Analysis | 4 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Transfection | 2 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Genes, ras/genetics | 3 | 2.0 |
Genotype | 2 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Animals | 12 | 0.0 |
Histocompatibility Antigens Class II/*immunology | 2 | 1.0 |
Amino Acid Sequence | 4 | 0.0 |
Comparative Study | 6 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Genetic Complementation Test | 2 | 0.0 |
Adolescent | 8 | 0.0 |
Child | 7 | 0.0 |
Child, Preschool | 3 | 0.0 |
Infant | 6 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Mice | 8 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
Genes, Tumor Suppressor/*genetics | 3 | 0.0 |
Genes, p53/genetics | 2 | 0.0 |
Point Mutation | 3 | 0.0 |
*Genes, APC | 2 | 2.0 |
Genes, ras | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Fatal Outcome | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Adenocarcinoma/*genetics/pathology | 2 | 2.0 |
Disease Progression | 3 | 0.0 |
Genes, Tumor Suppressor/genetics | 3 | 1.0 |
Pedigree | 3 | 0.0 |
Proteins/genetics | 2 | 0.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
*Chromosomes, Human, Pair 18 | 2 | 1.0 |
Linkage (Genetics) | 2 | 0.0 |
Leucine/*metabolism | 2 | 10.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Cell Transformation, Neoplastic/genetics | 2 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Prognosis | 2 | 0.0 |
*Carbon-Carbon Ligases | 3 | 23.0 |
Ligases/*deficiency | 3 | 30.0 |
Adenoma/*genetics | 2 | 2.0 |
Genetic Markers | 2 | 0.0 |
Intestinal Neoplasms/*genetics | 2 | 18.0 |
*Chromosome Mapping | 2 | 0.0 |
Crosses, Genetic | 3 | 0.0 |
Genes, Tumor Suppressor | 3 | 0.0 |
*Gene Deletion | 2 | 0.0 |
Adenomatous Polyposis Coli/*genetics | 2 | 3.0 |
Colorectal Neoplasms/*genetics | 2 | 0.0 |
*Oncogenes | 2 | 0.0 |
Carcinoma, Squamous Cell/*genetics | 2 | 1.0 |
Blotting, Southern | 4 | 0.0 |
*Genes, p53 | 2 | 0.0 |
*Heterozygote | 2 | 0.0 |
*Chromosomes, Human, Pair 5 | 3 | 1.0 |
*Chromosome Deletion | 2 | 0.0 |
